Viatris to Release Third Quarter 2023 Financial Results on November 7, 2023
/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) plans to release its third quarter 2023 financial results on Tuesday, November 7 after the close of the U.S....
Stay updated with breaking news from Scotta Smith. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) plans to release its third quarter 2023 financial results on Tuesday, November 7 after the close of the U.S....
Pharmaceuticals giant Viatris Inc. said Monday it has agreed to sell several business segments in a planned divestiture. The Cecil-based company will sell substantially all of its Over-the-Counter (OTC) business, Women’s Healthcare business, Active Pharmaceutical Ingredients business in India. The company is also selling commercialization rights that were acquired when
Total Gross Proceeds From All Divestitures, Including the 2022 Divestiture of the Company's Biosimilars Business, and the Estimated Retained Value are in Line with the Company's Previously Communicated RangeStrategic Decision Made to Retain Rights...
Total Gross Proceeds From All Divestitures, Including the 2022 Divestiture of the Company's Biosimilars Business, and the Estimated Retained Value are in Line...
Total Gross Proceeds From All Divestitures, Including the 2022 Divestiture of the Company's Biosimilars Business, and the Estimated Retained Value are in Line with the Company's Previously...